Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
153,881,229
-
Total 13F shares
-
9,536,513
-
Share change
-
+472,600
-
Total reported value
-
$133,985,000
-
Price per share
-
$14.05
-
Number of holders
-
39
-
Value change
-
+$6,730,351
-
Number of buys
-
24
-
Number of sells
-
10
Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q4 2020
As of 31 Dec 2020,
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,536,513 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Johnson & Johnson Innovation - JJDC, Inc., VANGUARD GROUP INC, Nantahala Capital Management, LLC, BlackRock Inc., BAILLIE GIFFORD & CO, Ikarian Capital, LLC, Artal Group S.A., J. Goldman & Co LP, and DAFNA Capital Management LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.